Keeping in tradition with the U’s commitment to advance the fields of medicine and surgery, our physicians are focusing on regenerative medicine as the next frontier in treating cardiovascular disease. Researchers within the Cardiovascular Center estimate cell therapy will be FDA-approved within three years. The goal of this therapy is to give cells back to the heart in order for it to grow stronger, work harder, and function more like a younger heart. Currently, studies include the potentiality of injecting cardiac repair cells into patients’ hearts to improve function.
This is the first trial of its kind in the United States, providing heart patients who have limited or no other options with a viable treatment. Using some of the best imaging technology, researchers have been able to see improvements in patients within six months after injecting their own cells directly into the left ventricle of the heart during minimally invasive surgery.
To contact us, please use the contact number provided.
Dr. Craig Selzman is a Professor of Surgery and Chief of the Division of Cardiothoracic Surgery at the University of Utah who specializes in the care of patients requiring heart surgery. He earned his undergraduate degree at Amherst College and medical degree at Baylor College of Medicine. He received his General and Cardiothoracic Surgery training... Read More
Adult Congenital Heart Disease, Cardiac Mechanical Support, Cardiothoracic Surgery, Coronary Revascularization, Heart Failure, Heart Stem Cell Therapy, Heart Transplant, Lung Transplant, Minimally Invasive Heart Surgery, Surgical Ventricular Restoration, Valvular Heart Disease
|University Hospital||50 N Medical Drive|
Salt Lake City, UT 84132
Giving Hope, Healing a Heart
H.E. Smith’s cardiologist told him to go home and get his affairs in order. “I went to a funeral home and made all of my arrangements,” said Smith, 72. That was nine years ago....Read More
Keywords: Stem Cell, Heart Failure, Ischemic Cardiomyopathy
- AC6 Trial
Keywords: Gene Therapy, Heart Failure, Cardiomyopathy
Status: Active, not recruiting
- TEVA CEP-41750
Keywords: Stem cells, Heart Failure, Regenerative Medicine, Cardiology, Gene therapy
- Aastrom HF 2B
Keywords: Stem Cells
Keywords: Stem Cell, Heart, Coronary Artery Disease, Ejection Fraction, ischemic heart disease
- LVAD and Stem Cells
Keywords: Heart Failure, LVAD, Stem Cells, Bridge to Transplant, Destination Therapy, Myocardial Recovery